A University of Tokyo spin-off, LPIXEL specializes in image analysis in the life sciences field. The company develops the “EIRL” series, an AI-powered diagnostic imaging support solution targeting major diseases such as lung cancer and colorectal cancer, which are among the leading causes of death. EIRL analyzes medical images captured by X-ray, CT, and MRI devices using artificial intelligence to assist physicians in their diagnoses.